Skip to content
Screener

CapEx at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.32B+26.7%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$86.4M+10.6%
Glaukos logo
GlaukosGKOS
$2.74M+132%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$77K-31.9%
HRO
HarrowHROW
$194K+14.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$4.66M+141%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash provided by operating activities18510
Cash Flows From Investing Activities
Acquisitions and other investments(53)(13)
Purchases of property, plant and equipment(171)(199)
Purchases of marketable securities(6)(5)
Proceeds from sale of marketable securities55
Proceeds from sale of assets and businesses, net of costs to sell3
Interest settlements from cross-currency swaps56

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's capex?
Bausch + Lomb (BLCO) reported capex of $71M in Q2 2026.
How has Bausch + Lomb's capex changed year-over-year?
Bausch + Lomb's capex decreased by 20.2% year-over-year, from $89M to $71M.
What is the long-term trend for Bausch + Lomb's capex?
Over 4 years (2021 to 2025), Bausch + Lomb's capex has grown at a 16.0% compound annual growth rate (CAGR), from $193M to $349M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Bausch + Lomb's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude